Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation

• Autore: Bodis Stephan
• Pubblicazione: Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
• Descrizione fisica: 1 online resource (346 p.)
• Soggetto topico: Medicine and Nursing; Oncology
• Soggetto non controllato: abscopal effect; adaptive planning; antigen pattern; bioelectromagnetics; biological modeling; biomarker; brachytherapy; breast cancer; cancer; cellular selection; cervical cancer; chemoradiotherapy; chemotherapy; clinical evidence; complexity; conductivity reconstruction; cost-effective; danger signal; deep hyperthermia; dendritic cell activation; fractionation; head and neck cancer; head and neck cancers; hyperthermia; hyperthermia treatment planning; hyperthermia treatment sequence; hypoxia; immune checkpoint molecules; immune phenotype; immune response; immune system in silico; immune-effects; induced; intensity-modulated radiotherapy; interstitial hyperthermia; linear quadratic model; local tumor control; locally advanced cervical cancer; loco-regional hyperthermia; low-middle-income group countries; meta-analysis; moderate hyperthermia; modulated electro-hyperthermia; n/a; neoadjuvant chemoradiation; oncology; oxygen consumption rate; patterns of care; perceptron; perfusion; perfusion estimation; preclinical data; prostate; prostate cancer; prostatic neoplasms; radiation therapy; radiative hyperthermia; radiosensitiser; radiotherapy; rectal cancer; recurrent breast cancers; regional hyperthermia; reimbursement; reirradiation; reoxygenation; resource-constrained setting; survival; systems medicine; temperature monitoring; temperature optimization; thermal dose; thermal dosimetry; thermometric parameters; thermoradiotherapy; treatment outcome; treatment plan optimization; tumour control
• Persona (resp. second.): GhadjarPirus; Van RhoonGerard C; BodisStephan
• Sommario/riassunto: The road of acceptance of oncologic thermotherapy/hyperthermia as a synergistic modality in combination with standard oncologic therapies is still bumpy. This is partially due to the lack of level I evidence from international, multicentric, randomized clinical trials including large patient numbers and a long term follow-up. Therefore we need more level I EVIDENCE from clinical trials, we need HARMONISATION and global acceptance for existing technologies and a common language understood by all stakeholders and we need INNOVATION in the fields of biology, clinics and technology to move thermotherapy/hyperthermia forward. This is the main focus of this reprint. In this reprintyou find carefully selected and peer-reviewed contributions from Africa, America, Asia, and Europe. The published papers from leading scientists from all over the world covering a broad range of timely research topics might also help to strengthen thermotherapy on a global level.
• Altri titoli varianti: Oncologic Thermoradiotherapy
• Titolo autorizzato: Oncologic Thermoradiotherapy: Need for Evidence, Harmonisation, and Innovation
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910580212603321
• Lo trovi qui: Univ. Federico II